Inflammatory mechanisms in Alzheimer's disease

European Archives of Psychiatry and Clinical Neuroscience

Volumn 246, Issue 3, 1996, Pages 124-128

  Hull M ^a   Strauss, S ^a   Berger, M ^a   Volk, B ^a   Bauer, J ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Alzheimer's disease; Interleukin 6; Primitive plaques; Senile plaques

Indexed keywords

ACUTE PHASE PROTEIN; ALPHA 1 ANTICHYMOTRYPSIN; C REACTIVE PROTEIN; CYTOKINE; INTERLEUKIN 6;

ALZHEIMER DISEASE; ASTROCYTE; BRAIN CORTEX; COMPLEMENT SYSTEM; HUMAN; INFLAMMATION; MICROGLIA; PRIORITY JOURNAL; SENILE PLAQUE; SHORT SURVEY;

ALZHEIMER DISEASE; AMYLOID; BRAIN; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; SYNAPSES;

EID: 0029933332     PISSN: 09401334     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02189112     Document Type: Article

References (36)

1. Abraham CR, Selkoe DJ, Potter H (1988) Immunochemical identification of the serine protease inhibitor aipha 1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease. Cell 52 : 487-501
2. Aisen PS, Davis KL (1994) Inflammatory mechanisms in Alzheimer's disease: implications for therapy. Am J Psychiatry 151 : 1105-1113
3. Bancher C, Braak H, Fischer P, Jellinger KA (1993) Neuropathological staging of Alzheimer lesions and intellectual status in Alzheimer's and Parkinson's disease patients. Neurosci Lett 162 : 179-182
4. Bauer J (1989) Interleukin-6 and its receptor during homeostasis, inflammation and tumor growth. Klin Wochenschr 67 : 697-706
5. Bauer J, Herrmann F (1991) Interleukin-6 in clinical medicine. Ann Hematol 62 : 203-213
6. Bauer J, Strauss S, Schreiter-Gasser U, Ganter U, Schlegel P, Witt I, Volk B, Berger M (1991) Interleukin-6 and α2-macroglobulin indicate an acute phase state in Alzheimer's disease cortices. FEBS Lett 285 : 111-114
7. Baumann H, Gauldie J (1994) The acute phase response. Immunol Today 15 : 74-80
8. Berg L, McKeel DWJ, Miller JP, Baty J, Morris JC (1993) Neuropathological indexes of Alzheimer's disease in demented and nondemented persons aged 80 years and older. Arch Neurol 50 : 349-358
9. Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol Berl 82 : 239-259
10. Breitner JCS, Gau BA, Welsh KA, Plassmann BL, McDonald WM, Helms MJ, Anthony JC (1994) Inverse association of antiinflammatory treatments and Alzheimer's disease: intial results of a co-twin control study. Neurology 44 : 227-232
11. Crystal HA, Dickson DW, Sliwinski MJ, Lipton RB, Grober E, Marks-Nelson H, Antis P (1993) Pathological markers associated with normal aging and dementia in the elderly. Ann Neurol 34 : 1682-1687
12. DeKosky ST, Scheff SW (1990) Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity. Ann Neurol 27 : 457-464
13. DeRijk RH, Boelen A, Tilders FJH, Berkenbosch F (1994) Induction of plasma interleukin-6 by circulating adrenaline in rat. Psychoneuroendocrinology 19 : 155-163
14. Dickson DW, Lee SC, Mattiace LA, Yen SC, Brosnan C (1993) Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease. Glia 7 : 75-83
15. Ershler WB (1993) Interleukin-6: a cytokine for gerontologists. J Am Geriatr Soc 41 : 176-181
16. Gallo P, Frei K, Rordorf C, Lazdins J, Tavolta B, Fontana A (1989) Human immunodeficiency virus type 1 (HIV-1) infection of the central nervous system: an evaluation of cytokines in the cerebrospinal fluid. J Neuroimmunol 23 : 109-116
17. Gottschall PE, Tatsuno I, Arimura A (1994) Regulation of interleukin 6 (IL-6) secretion in primary cultured rat astrocytes: synergism of mterleukin 1 (IL-1) and pituitary adenylate cyclase activating polypeptide (PACAP). Brain Res 637 : 197-203
18. Hager K, Machein U, Krieger S, Seefried G, Bauer J (1994) Plasma concentrations of interleukin-6 and selected plasma proteins in healthy persons of different ages. Neurobiol Aging 15 : 771-772
19. Helfgott DC, Tatter SB, Santhanam U, Clarick RH, Bhardwaj N, May L, Seghal BP (1989) Multiple forms of IFNβ2/IL-6 in serum and body fluids during acute bacterial infection. J Immunol 142 : 948-953
20. Higuchi M, Ito T, Iwaki T, Hattori M, Kohsaka S, Niho Y, Sakaki Y (1994) Expression of the alpha-2-macroglobulin-encoding gene in rat brain and cultured astrocytes. Gene 141 : 155-162
21. Jellinger K, Bancher C, Fischer P, Lassmann H (1992) Quantitative histopathologic validation of senile dementia of the Alzheimer type. Eur J Gerontol 3 : 146-156
22. Khachaturian ZS (1985) Diagnosis of Alzheimer's disease. Arch Neurol 42 : 1097-1104
23. Laurenzi MA, Siden A, Persson MA, Norkrans G, Hageberg L, Chiodi F (1990) Cerebrospinal fluid interleukin-6 activity in HIV infection and inflammatory and non-inflammatory diseases of the nervous system. Clin Immunol Immunopathol 57 : 233-241
24. Maimone D, Cioni C, Rosa S, Macchia G, Aloisi F, Annunziata P (1993) Norepinephrine and vasoactive intestinal peptide induce IL-6 secretion by astrocytes: synergism with IL-1beta and TN-Falpha. J Neuroimmunol 47 : 73-82
25. McGeer PL, Akiyama H, Itagaki S, McGeer EG (1989) Activation of the classical complement pathway in brain tissue of Alzheimer patients. Neurosci Lett 107 : 341-346
26. McGeer PL, Kawamata T, Walker DG, Akiyama H, Tooyama I, McGeer EG (1993) Microglia in degenerative neurological disease. Glia 7 : 84-92
27. Minami M, Kuraishi Y, Satoh M (1991) Effects of kainic acid on mRNA levels of IL-1 beta, IL-6, TNFalpha and LIF in the rat brain. Biochem Biophys Res Commun 176 : 593-598
28. Murphy DGM, Bottomley PA, Salerno JA, DeCarli C, Mentis MJ, Grady CL, Teichberg D, Giacometti KR, Rosenberg JM, Hardy CJ, Schapiro MB, Rapaport SI, Alger JR, Horwitz B (1993) An in vivo study of phosphorus and glucose metabolism in Alzheimer's disease using magnetic resonance spectroscopy and PET. Arch Gen Psychiatry 50 : 341-349
29. Norris JG, Benveniste EN (1993) Interleukin-6 production by astrocytes: induction by the neurotransmitter norepinephrine. J Neuroimmunol 45 : 137-146
30. Rich JB, Rasmusson DX, Folstein MF, Carson KA, Kawas C, Brandt J (1995) Nonsteroidal anti-inflammatory drugs in Alzheimer's disease. Neurology 45 : 51-55
31. Rogers J, Kirby LC, Hempdman SR, Berry DL, McGeer PL, Kaszniak AW, Zalinski J, Cofield M, Mansukhani L, Willson P et al. (1993) Clinical trial of indomethacin in Alzheimer's disease. Neurology 43 : 1609-1611
32. Sparks D, Liu H, Scheff SW, Coyne CM, Hunsaker JC (1993) Temporal sequence of plaque formation in the cerebral cortex of non-demented individuals. J Neuropathol Exp Neurol 52 : 135-142
33. Strauss S, Bauer J, Ganter U, Jonas U, Berger M, Volk B (1992) Detection of interleukin 6 and alpha-2-macroglobulin immunoreactivity in cortex and hippocampus of Alzheimer's disease patients. Lab Invest 66 : 223-230
34. Terry RD, Masliah E, Salmon DP, Butters N, DeTeresa R, Hill R, Hansen LA, Katzman R (1991) Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol 30 : 572-580
35. Wood J, Wood P, Ryan R, Graff-Radford NR, Pilapil C, Robitaille Y, Quirion R (1993) Cytokine indices in Alzheimer's temporal cortex: no changes in mature IL-1 beta or IL-1 RA but increases in the associated acute phase proteins IL-6, alpha-2-macroglobulin and C-reactive protein. Brain Res 629 : 245-252
36. Yamamoto T, Hirano A (1986) A comparative study by modified Bielschowsky, Bodian and thioflavin S stains on Alzheimer's neurofibrillary tangles. Neuropathol Appl Neurobiol 12 : 3-9